ReviewMolecular genetics and genomics : MGG2026
Unraveling the molecular landscape: an overview on gene expression, epigenetic alterations, and therapeutic challenges in head and neck squamous cell carcinoma.
Review in Molecular genetics and genomics : MGG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review aimed to provide a comprehensive overview of the molecular landscape of HNSCC, focusing on key genetic alterations, epigenetic regulation, and therapeutic challenges associated with HNSCC. We highlighted the deregulations in key cellular signaling pathways, including PI3K/AKT/mTOR, Ras/Raf/MEK/ERK, Wnt/Beta-catenin, Notch, Hedgehog, Hippo-YAP/TAZ, and JAK/STAT, which contribute to tumor initiation, progression, and therapy resistance. In addition, we provided an overview of epigenetic mechanisms in HNSCC including DNA methylation changes, histone modifications, and non-coding RNA regulation. Emerging epigenetic therapeutic strategies under clinical investigation were also highlighted. Moreover, molecular and epigenetic signatures related to HPV-positive and HPV-negative HNSCC further emphasized the complexity and clinical heterogeneity of disease. Head and Neck Squamous Cell Carcinoma (HNSCC) represents a biologically complex malignancy characterized by molecular heterogeneity, high recurrence rate, and poor clinical outcome. A deeper understanding of the genetic and epigenetic mechanisms underlying HNSCC is essential for improving early diagnosis, and therapy response providing a better patient stratification. An extensive review of current literature was conducted using PubMed and Google Scholar which included 280 articles highlighting recent advancements in gene expression profiling in HNSCC. This review summarizes the complex molecular events in HNSCC emphasizing the key deregulations in cellular signaling pathways, differential gene expression regulated by epigenetic modifications. Understanding these molecular mechanisms may facilitate the identification of novel biomarkers and therapeutic targets, contributing to the development of more effective treatment for HNSCC.
Indexed as
Identifiers
41940897What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.